Independent review of trial event assessments by adjudication experts.
Proven expertise in delivering high-quality imaging data at a global scale.
With strengths in instrument engineering, signal processing, and pharmaceutical R&D, Perceptive Discovery consistently delivers successful imaging study designs and executions.
Effective RTSM, built on 30 years of experience, and connected to an ecosystem which includes eConsent and eCOA.
Highly established imaging centers for first-in-human and multicenter trials.
900+ agents radiolabeled and counting.
Supporting both malignant and non-malignant indications.
Experts in Alzheimer’s Disease, Parkinson’s Disease imaging and more.
Supporting over 85% of radiopharmaceutical companies.
Optimize preclinical and clinical trials in other areas and drug classifications.
Therapeutic and technical expertise in imaging modalities, protocol design, and acquisition.
Oncology imaging, RTSM, and clinical adjudication services.
Tackling unique rare disease trial supply, imaging and adjudication challenges.
Body composition imaging expertise you can rely on.
We are here to serve science.
From discovery, through early to late-phase clinical development, to regulatory approval and post-market, you can count on Perceptive to be dependable, diligent, and driven in everything we do.
Perceptive Discovery bridges preclinical insights to early clinical success, ensuring rigorous scientific analysis and high-quality data to support innovation.
Providing the right-fit randomization & trial supply management solution for your trials, delivered by experts.
The right people, experience, and technology to drive clinical trial imaging success.
Perceptive is a trusted imaging core lab for oncology clinical trials, having supported over 1,800 studies and more than 300 regulatory approvals to date.
Learn about our expertise in:
Whether your study involves RECIST, Lugano, mRECIST, RANO or other oncology imaging endpoints, radioligand therapies, or complex clinical biomarker integration, our scalable medical imaging oncology services deliver the expertise and infrastructure needed to meet the highest data standards and regulatory rigor.
From Phase I oncology trials to pivotal registration studies, our imaging core lab supports every step of your imaging workflow. For trials exploring advanced endpoints, we offer cutting-edge image analysis capabilities, including radiomics and AI-powered pipelines, enabling deeper insights into tumor response and progression.
Imaging strategy and study designs are led by board-certified radiologists and oncology imaging experts who bring decades of experience in oncology clinical development and regulatory engagement.
We deliver the precision and flexibility you need, whether your study involves conventional CT and MRI scans or specialized imaging for novel mechanisms of action like radioligand therapies and antibody drug conjugates (ADC).
We support the whole range of oncology indications — including breast cancer, renal cell carcinoma, lung cancer, CNS tumors and hematologic malignancies — with tailored imaging strategies that reflect the nuances of each disease area.
Our proprietary, technology-enabled platform streamlines image quality control, reader performance monitoring, and data delivery — delivering greater insights to help inform confident decision making, faster.
With zero observations across FDA, EMA, and NMPA inspections over the past decade, our inspection readiness program and quality systems are proven to meet global regulatory expectations.
Whether your study is fast-tracked at the start or becomes accelerated later, trust Perceptive’s scalable operational model and global employees to deliver harmonized, 24/7 support that scales to meet timelines and drive your trial’s success.
Perceptive Imaging brings significant experience in solid tumor clinical trial imaging, supporting all phases of clinical development and helping sponsors meet global regulatory expectations, across both standard-of-care and advanced medical imaging.
Our scientific and operational teams work in lockstep to ensure imaging strategies are aligned with regulatory expectations from day one — reducing risk, accelerating timelines, and supporting breakthrough designations.
Contact us to discuss other capabilities not listed below, or other, emerging solutions for your study.
Our expertise includes, but is not limited to:
Vice President of Medical Services, a board-certified radiologist with over 25 years of experience in medical imaging and a recognized expert in imaging biomarkers across therapeutic areas.
A recognized authority in clinical trial imaging for more than 20 years and a co-author of both irRC and irRECIST. His leadership ensures that every imaging strategy is grounded in the latest science and regulatory expectations.
We’re pioneering radiopharmacuticals.
Multiple Myeloma Imaging, Leukemia Imaging, Lymphoma Imaging, and Myelofibrosis Imaging
Hematologic malignancy trial imaging is especially complex. Multiple Myeloma, Lymphoma, and Leukemia trials require not only clinical trial imaging, but also the integration of complex clinical data to support efficacy endpoints. And Myelofibrosis trials require multiple imaging modalities and specialized expertise to demonstrate treatment effect with confidence.
Having supported over 360 malignant hematology trials and 69 regulatory approvals, our imaging core lab services have been proven to meet these challenges head on. The result? You don’t have to worry about gaps or delays, and you gain confidence that your imaging data is high-quality and regulator-ready.
As trial complexity increases, so does the likelihood for things to go wrong – but not with Perceptive Imaging.
We have the people, processes, and infrastructure to keep your trial on track. Our integrated imaging and clinical data workflows are proven, scalable, regulator-aligned, and ready to meet the most complex trial needs.
Senior Medical Director and Head of Hemato-Oncology, with two decades of experience in clinical development and deep specialization in hematologic malignancies.
Reach out today and one of our solution experts will be in touch to learn about your specific needs.
"*" indicates required fields
Δ
